Showing results (71-80 of 129) with videos related to

Sort By:
Pageof 13
Advances in Therapy|April 4, 2024
Safety and Efficacy of Pegcetacoplan in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria over 48 Weeks: 307 Open-Label Extension StudyChristopher J Patriquin, Andrija Bogdanovic, Morag Griffin, et al.
Hematology (Amsterdam, Netherlands)|December 12, 2024
Expert consensus on the management of pharmacodynamic breakthrough-hemolysis in treated paroxysmal nocturnal hemoglobinuriaDavid Dingli, Carlos De Castro Iii, Jamie Koprivnikar, et al.
European Journal of Haematology|January 2, 2024
Relevance of different prognostic scores in primary CNS lymphoma in the era of intensified treatment regimens: A retrospective, multicenter analysis of 174 patientsVanja Zeremski, Louisa Adolph, Sina Beer, et al.
Hemasphere|July 15, 2026
Switching between complement inhibitors in paroxysmal nocturnal hemoglobinuria: Analysis of strategy, efficacy, and safetyMorag Griffin, Bruno Fattizzo, Jong Wook Lee, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 11, 2009
Low-dose total body irradiation and fludarabine conditioning for HLA class I-mismatched donor stem cell transplantation and immunologic recovery in patients with hematologic malignancies: a multicenter trialHirohisa Nakamae, Barry E Storer, Rainer Storb, et al.
Leukemia|May 7, 2026
CAR T-cells targeting CD117 effectively eliminate mast cells in preclinical models of advanced systemic mastocytosisAnne Kaiser, Veronika Lysenko, Renier Myburgh, et al.
Journal of Hematology & Oncology|April 24, 2025
PFS24 as a prognostic milestone in patients with newly diagnosed primary CNS lymphomaVanja Zeremski, Tobias R Haage, Hanno M Witte, et al.
Annals of the New York Academy of Sciences|October 25, 2019
Comparison of flow-FISH and MM-qPCR telomere length assessment techniques for the screening of telomeropathiesMonica S Ventura Ferreira, Martin Kirschner, Insa Halfmeyer, et al.
European Journal of Haematology|June 15, 2023
Crovalimab treatment in patients with paroxysmal nocturnal haemoglobinuria: Long-term results from the phase I/II COMPOSER trialAlexander Röth, Satoshi Ichikawa, Yoshikazu Ito, et al.
Blood Advances|May 31, 2022
Efficacy and safety of avapritinib in previously treated patients with advanced systemic mastocytosisAndreas Reiter, Juliana Schwaab, Daniel J DeAngelo, et al.
Pageof 13